Filtros : "Hassanie, Haifa" Limpar

Filtros



Refine with date range


  • Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF

    Subjects: NEOPLASIAS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 27 set. 2024.
    • APA

      Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
    • NLM

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 set. 27 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
    • Vancouver

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 set. 27 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
  • Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidade: FCF

    Subjects: CANABINOIDES, ANTINEOPLÁSICOS

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      EL HAJJE, Marissa e HASSANIE, Haifa e TROSSINI, Gustavo Henrique Goulart. Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 27 set. 2024.
    • APA

      El Hajje, M., Hassanie, H., & Trossini, G. H. G. (2023). Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
    • NLM

      El Hajje M, Hassanie H, Trossini GHG. Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates [Internet]. Anais. 2023 ;[citado 2024 set. 27 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
    • Vancouver

      El Hajje M, Hassanie H, Trossini GHG. Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates [Internet]. Anais. 2023 ;[citado 2024 set. 27 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
  • Source: Future Medicinal Chemistry. Unidades: FCFRP, FCF

    Subjects: METABOLISMO, PLANEJAMENTO DE FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PENTEADO, André Berndt et al. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, v. 15, n. 3, p. 291-311, 2023Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0253. Acesso em: 27 set. 2024.
    • APA

      Penteado, A. B., Hassanie, H., Gomes, R. A., Emery, F. da S., & Trossini, G. H. G. (2023). Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, 15( 3), 291-311. doi:10.4155/fmc-2022-0253
    • NLM

      Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2024 set. 27 ] Available from: https://doi.org/10.4155/fmc-2022-0253
    • Vancouver

      Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2024 set. 27 ] Available from: https://doi.org/10.4155/fmc-2022-0253
  • Source: Scientific Reports. Unidade: FCF

    Subjects: NEOPLASIAS CEREBRAIS, QUIMIOTERAPIA, RADIOTERAPIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES JUNIOR, Dorival Mendes et al. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-25534-2. Acesso em: 27 set. 2024.
    • APA

      Rodrigues Junior, D. M., Raminelli, C., Hassanie, H., Trossini, G. H. G., Perecim, G. P., Puigsubira, L. C., et al. (2022). Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, 12, 1-17. doi:10.1038/s41598-022-25534-2
    • NLM

      Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 set. 27 ] Available from: https://doi.org/10.1038/s41598-022-25534-2
    • Vancouver

      Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 set. 27 ] Available from: https://doi.org/10.1038/s41598-022-25534-2

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024